Back to search

Article

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical Trial

2020-07-14

Abstract excerpt

Background: No effective drug treatments are yet available for coronavirus disease 2019 (COVID-19). Host-directed therapies targeting the underlying aberrant immune responses leading to pulmonary tissue damage, consequential functional disability and even death require evaluation in clinical trials. We performed an open label phase 1, parallel assigned controlled, clinical trial to evaluate the safety of human umb...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9778c800-7d95-58d9-ae98-8d11747ad1a8
DOI
10.2139/ssrn.3612127
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical TrialDOI 10.2139/ssrn.3612127
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialSemantic proximity
The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity
Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity
Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospectsSemantic proximity
COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based TherapySemantic proximity
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreakSemantic proximity
The Saudi Critical Care Society Practice Guidelines on the Management of COVID-19 in the ICU: Therapy SectionSemantic proximity
Safety of Allogeneic Mesenchymal Stromal Cell Therapy Across Human Clinical Indications: A Systematic Review of Landmark Clinical Trials and Published Safety EvidenceSemantic proximity
Combating COVID-19 with mesenchymal stem cell therapySemantic proximity
Mesenchymal Stem Cells Impact on COVID-19 Patients Immune System, an Ex Vivo StudySemantic proximity
Select a neighboring publication to make it the new centre.